SuperworthCitius Pharmaceuticals shares outstanding CTXR
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 26.2M
- On a year earlier
- +137.8%
- more shares
Citius Pharmaceuticals had 26.2M diluted shares outstanding on average in Q3 FY26, the quarter to Jun 30, 2026.
That is 137.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 17.1M | +137% |
| FY2024 | 7.2M | −95% |
| FY2023 | 158.9M | +9% |
| FY2022 | 146.1M | +0% |
| FY2021 | 146M | +183% |
| FY2020 | 51.5M | +130% |
| FY2019 | 22.4M | +64% |
| FY2018 | 13.6M | +95% |
| FY2017 | 7M | +43% |
| FY2016 | 4.9M | +116% |
| FY2015 | 2.3M | +42% |
| FY2014 | 1.6M | +33% |
| FY2013 | 1.2M | +0% |
| FY2012 | 1.2M | +0% |
| FY2011 | 1.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 26.2M | +138% | |
| Q2 FY26 | 22.4M | +161% | |
| Q1 FY26 | 21.5M | +187% | |
| Q4 FY25 | 17.1M | +137% | |
| Q3 FY25 | 11M | +58% | |
| Q2 FY25 | 8.6M | +35% | |
| Q1 FY25 | 7.5M | +18% | |
| Q4 FY24 | 7.2M | −95% | |
| Q3 FY24 | 7M | −95% | |
| Q2 FY24 | 6.4M | −96% | |
| Q1 FY24 | 6.4M | −96% | |
| Q4 FY23 | 158.9M | +9% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Citius Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.